Home Cart 0 Sign in  

[ CAS No. 121-60-8 ]

{[proInfo.proName]} ,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 121-60-8
Chemical Structure| 121-60-8
Structure of 121-60-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Quality Control of [ 121-60-8 ]

Related Doc. of [ 121-60-8 ]

Alternatived Products of [ 121-60-8 ]

Product Details of [ 121-60-8 ]

CAS No. :121-60-8 MDL No. :MFCD00007442
Formula : C8H8ClNO3S Boiling Point : -
Linear Structure Formula :- InChI Key :GRDXCFKBQWDAJH-UHFFFAOYSA-N
M.W :233.67 Pubchem ID :8481
Synonyms :

Safety of [ 121-60-8 ]

Signal Word:Danger Class:8
Precautionary Statements:P261-P280-P305+P351+P338-P310 UN#:3261
Hazard Statements:H314-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 121-60-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 121-60-8 ]
  • Downstream synthetic route of [ 121-60-8 ]

[ 121-60-8 ] Synthesis Path-Upstream   1~28

  • 1
  • [ 96-50-4 ]
  • [ 121-60-8 ]
  • [ 72-14-0 ]
Reference: [1] European Journal of Medicinal Chemistry, 2017, vol. 136, p. 63 - 73
  • 2
  • [ 121-60-8 ]
  • [ 72-14-0 ]
Reference: [1] Zhurnal Prikladnoi Khimii (Sankt-Peterburg, Russian Federation), 1944, vol. 17, p. 65,73[2] Chem.Abstr., 1945, p. 1410
[3] Journal of the American Chemical Society, 1939, vol. 61, p. 2032
[4] Proceedings - Indian Academy of Sciences, Section A, 1940, # 11, p. 298,307
[5] Patent: US2438177, 1939, ,
[6] Journal of Sulfur Chemistry, 2016, vol. 37, # 5, p. 515 - 528
[7] Crystal Growth and Design, 2018, vol. 18, # 3, p. 1339 - 1349
[8] Patent: US2366189, 1939, ,
  • 3
  • [ 1072-67-9 ]
  • [ 121-60-8 ]
  • [ 723-46-6 ]
Reference: [1] European Journal of Medicinal Chemistry, 2017, vol. 136, p. 63 - 73
  • 4
  • [ 121-60-8 ]
  • [ 723-46-6 ]
Reference: [1] Shionogi Kenkyusho Nenpo, 1957, # 7, p. 301,304[2] Chem.Abstr., 1957, p. 17889
[3] Patent: US2888455, 1957, ,
[4] ACS Medicinal Chemistry Letters, 2014, vol. 5, # 1, p. 12 - 17
[5] European Journal of Medicinal Chemistry, 2015, vol. 101, p. 595 - 603
  • 5
  • [ 13752-78-8 ]
  • [ 121-60-8 ]
  • [ 723-46-6 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1966, vol. 14, # 11, p. 1277 - 1286
  • 6
  • [ 25109-76-6 ]
  • [ 121-60-8 ]
  • [ 723-46-6 ]
Reference: [1] Monatshefte fuer Chemie, 1970, vol. 101, p. 1109 - 1122
  • 7
  • [ 109-12-6 ]
  • [ 121-60-8 ]
  • [ 68-35-9 ]
Reference: [1] European Journal of Medicinal Chemistry, 2017, vol. 136, p. 63 - 73
  • 8
  • [ 121-60-8 ]
  • [ 68-35-9 ]
Reference: [1] Dansk Tidsskrift for Farmaci, 1942, vol. 16, p. 141,150
[2] Patent: CH230861, 1938, ,
[3] Journal of the American Chemical Society, 1940, vol. 62, p. 2002,2003[4] Journal of the American Chemical Society, 1942, vol. 64, p. 567,568
[5] Patent: WO2017/156181, 2017, A1,
  • 9
  • [ 108-52-1 ]
  • [ 121-60-8 ]
  • [ 127-79-7 ]
Reference: [1] European Journal of Medicinal Chemistry, 2017, vol. 136, p. 63 - 73
  • 10
  • [ 121-60-8 ]
  • [ 127-79-7 ]
Reference: [1] Journal of the American Chemical Society, 1942, vol. 64, p. 2340
[2] Patent: CH230863, 1938, ,
[3] Journal of the American Chemical Society, 1941, vol. 63, p. 3028
[4] Journal of the American Chemical Society, 1940, vol. 62, p. 2002,2003[5] Journal of the American Chemical Society, 1942, vol. 64, p. 567,568
[6] Recueil des Travaux Chimiques des Pays-Bas, 1942, vol. 61, p. 627,666,667
[7] J.Chin.chem.Soc., 1947, vol. 15, p. 138,145
  • 11
  • [ 121-60-8 ]
  • [ 144-82-1 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1943, vol. 62, p. 207
[2] Archiv der Pharmazie (Weinheim, Germany), 1951, vol. 284, p. 53,57
[3] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 6, p. 2046 - 2054
[4] Patent: WO2009/129267, 2009, A2,
  • 12
  • [ 108-33-8 ]
  • [ 121-60-8 ]
  • [ 144-82-1 ]
Reference: [1] Patent: CH230860, 1938, ,
[2] Patent: DE957841, 1957, ,
[3] Proceedings - Indian Academy of Sciences, Section A, 1941, # 13, p. 386,387
  • 13
  • [ 2302-95-6 ]
  • [ 121-60-8 ]
  • [ 144-82-1 ]
Reference: [1] Patent: US2447702, 1942, ,
  • 14
  • [ 121-60-8 ]
  • [ 57-68-1 ]
Reference: [1] Journal of the American Chemical Society, 1941, vol. 63, p. 2188
[2] Patent: CH230865, 1938, ,
  • 15
  • [ 19947-75-2 ]
  • [ 121-60-8 ]
  • [ 127-69-5 ]
Reference: [1] Crystal Growth and Design, 2013, vol. 13, # 9, p. 4002 - 4016
[2] DRP/DRBP Org.Chem.,
[3] Patent: DE819855, 1951, ,
  • 16
  • [ 121-60-8 ]
  • [ 127-69-5 ]
Reference: [1] Yakugaku Zasshi, 1951, vol. 71, p. 1356,1358[2] Chem.Abstr., 1952, p. 8036
[3] Yakugaku Zasshi, 1951, vol. 71, p. 1356,1358[4] Chem.Abstr., 1952, p. 8036
[5] Antimicrobial Agents and Chemotherapy, 2014, vol. 58, # 5, p. 2968 - 2971
  • 17
  • [ 7252-84-8 ]
  • [ 121-60-8 ]
  • [ 80-35-3 ]
Reference: [1] European Journal of Medicinal Chemistry, 2017, vol. 136, p. 63 - 73
  • 18
  • [ 1072-67-9 ]
  • [ 121-60-8 ]
  • [ 21312-10-7 ]
YieldReaction ConditionsOperation in experiment
59% at 20℃; for 12 h; A mixture of 4-acetamidobenzene-1-sulfonyl chloride (4.27 mmol), 5-methylisoxazol-3-amine (4.49 mmol) and DMAP (0.21 mmol) in anhydrous pyridine (10 mL) was stirred at room temperature for 12 h.
After completion of reaction, solvent was evaporated to dryness and diluted with water and extracted with ethyl acetate.
The combined organic layers were washed with water and 1 M aqueous HCl, dried over anhydrous Na2SO4, filtered, and concentrated under vacuum.
The solid residue obtained was purified with flash column chromatography using heptanes to EtOAc (50-100percent) gradient elution to afford the compound 2. 4.2.1
N-(4-(N-(5-Methylisoxazol-3-yl)sulfamoyl)phenyl)acetamide (2)
Yield: 59percent; ESIMS m/z calcd for C12H13N3O4S [M + H]+, 296.07; found 296.06; 1H NMR (400 MHz, (CD3)2SO): δ 11.30 (bs, 1H), 10.35 (bs, 1H), 7.79-7.73 (m, 4H), 6.12 (s, 1H), 2.29 (s, 3H), 2.07 (s, 3H).
13C (100 MHz, (CD3)2SO): δ 170.71, 169.57, 158.07, 144.01, 133.36, 128.50, 119.15, 95.84, 24.57, 12.48.
Reference: [1] ACS Medicinal Chemistry Letters, 2014, vol. 5, # 1, p. 12 - 17
[2] European Journal of Medicinal Chemistry, 2015, vol. 101, p. 595 - 603
[3] Shionogi Kenkyusho Nenpo, 1957, # 7, p. 301,304[4] Chem.Abstr., 1957, p. 17889
[5] Patent: US2888455, 1957, ,
[6] Crystal Growth and Design, 2013, vol. 13, # 9, p. 4002 - 4016
[7] Patent: CN105884705, 2016, A, . Location in patent: Paragraph 0013; 0016; 0021; 0026; 0031
  • 19
  • [ 121-60-8 ]
  • [ 122-11-2 ]
Reference: [1] Monatshefte fuer Chemie, 1956, vol. 87, p. 136,142
  • 20
  • [ 4774-10-1 ]
  • [ 121-60-8 ]
  • [ 152-47-6 ]
Reference: [1] Crystal Growth and Design, 2013, vol. 13, # 9, p. 4002 - 4016
  • 21
  • [ 3731-53-1 ]
  • [ 121-60-8 ]
  • [ 144-80-9 ]
Reference: [1] Patent: US6369086, 2002, B1,
  • 22
  • [ 121-60-8 ]
  • [ 7146-68-1 ]
Reference: [1] Gazzetta Chimica Italiana, 1949, vol. 79, p. 621,625
[2] Patent: WO2014/26039, 2014, A2,
  • 23
  • [ 110-86-1 ]
  • [ 23549-24-8 ]
  • [ 121-60-8 ]
  • [ 853-23-6 ]
Reference: [1] Journal of Organic Chemistry, 1956, vol. 21, p. 520
  • 24
  • [ 121-60-8 ]
  • [ 2360-19-2 ]
Reference: [1] Journal of the Chemical Society, 1939, p. 608
  • 25
  • [ 100-01-6 ]
  • [ 121-60-8 ]
  • [ 122-16-7 ]
YieldReaction ConditionsOperation in experiment
40% at 20℃; General procedure: To a solution of the aniline 1a-l (1 eq) in pyridine (1.6 mL/mmol) was added4-acetamidobenzenesulfonyl chloride (1.1 eq), the mixture was stirred at room temperature overnight, quenched with water and extracted three times with EtOAc. The combinedorganic layers were washed three times with 0.5 N HCl, three times with water and oncewith brine. The organic phase was then dried with anhydrous MgSO4, filtered, andconcentrated to give the title compound as a solid.
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 18, p. 4426 - 4430
[2] Patent: US2282769, 1939, ,
[3] Journal of the American Chemical Society, 1939, vol. 61, p. 613,616
[4] DRP/DRBP Org.Chem.,
[5] Canadian Journal of Research, Section B: Chemical Sciences, 1942, vol. 20, p. 5,7, 9
[6] Journal of the American Chemical Society, 1938, vol. 60, p. 1553
[7] Journal of Organic Chemistry, 1947, vol. 12, p. 275,278, 280
[8] Phosphorus, Sulfur and Silicon and the Related Elements, 2009, vol. 184, # 1, p. 92 - 102
[9] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 16, p. 4574 - 4578
[10] Crystal Growth and Design, 2011, vol. 11, # 4, p. 1067 - 1081
[11] Journal of Enzyme Inhibition and Medicinal Chemistry, 2012, vol. 27, # 5, p. 628 - 640
[12] DRP/DRBP Org.Chem.,
[13] Patent: US2282769, 1939, ,
  • 26
  • [ 121-60-8 ]
  • [ 587850-67-7 ]
Reference: [1] Journal of the Indian Chemical Society, 1941, vol. 18, p. 316,319
  • 27
  • [ 121-60-8 ]
  • [ 599-79-1 ]
Reference: [1] Patent: CN105330599, 2016, A,
  • 28
  • [ 121-60-8 ]
  • [ 245342-14-7 ]
Reference: [1] Patent: EP2219635, 2017, B1,
Same Skeleton Products
Historical Records